688566 logo

Jiangsu Jibeier Pharmaceutical Co., Ltd. Stock Price

SHSE:688566 Community·CN¥5.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

688566 Share Price Performance

CN¥0
-23.01 (-100.00%)
CN¥0
-23.01 (-100.00%)
Price CN¥0

688566 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet second-rate dividend payer.

1 Risk
2 Rewards

Jiangsu Jibeier Pharmaceutical Co., Ltd. Key Details

CN¥957.8m

Revenue

CN¥100.4m

Cost of Revenue

CN¥857.3m

Gross Profit

CN¥615.7m

Other Expenses

CN¥241.7m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 28, 2026
1.21
89.51%
25.23%
0.9%
View Full Analysis

About 688566

Founded
2001
Employees
1326
CEO
Zhongyi Geng
WebsiteView website
www.jbepharm.com

Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the drug research and development and production in China. The company’s products cover multiple therapeutic areas such as increasing white blood cells, fighting hypertension, enhancing immunity, treating joint diseases, fighting eye infections, treating bronchitis, protecting liver function, etc. It is also developing drugs for the treatment of depression, tumors, stomach and gastric diseases, and other diseases. In addition, the company offers its products in tablets, capsules, and eye drops forms. Jiangsu Jibeier Pharmaceutical Co., Ltd. was founded in 2001 and is based in Zhenjiang, China.

Recent 688566 News & Updates

Recent updates

No updates